Trinity Biotech Ownership 2024 | Who Owns Trinity Biotech Now?


OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

15.70%

Insider Ownership

19.68%

Retail Ownership

64.62%

Institutional Holders

26.00

Trinity Biotech Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
US BANCORP \DE\----972-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/----1,204-100.00%-Mar 31, 2024
BECKER CAPITAL MANAGEMENT INC----90,000-100.00%-Mar 31, 2024
CITIGROUP INC----4-100.00%-Mar 31, 2024
MORGAN STANLEY----14,552-100.00%-Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----684,882-100.00%-Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC----1,353,898-100.00%-Mar 31, 2024
ATWOOD & PALMER INC----100-100.00%-Mar 31, 2024
RHUMBLINE ADVISERS----1,860-100.00%-Mar 31, 2024
STONEHILL CAPITAL MANAGEMENT LLC----1,512,975-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----15,466-100.00%-Mar 31, 2024
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC----1,625,900-100.00%-Mar 31, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----111,400-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----1,000-100.00%-Mar 31, 2024
TWO SIGMA SECURITIES, LLC----19,037-100.00%-Mar 31, 2024
STATE OF NEW JERSEY COMMON PENSION FUND D----27,062-100.00%-Mar 31, 2024
ARISTIDES CAPITAL LLC----28,057-100.00%-Mar 31, 2024
DYNAMIC ADVISOR SOLUTIONS LLC----10,000-100.00%-Mar 31, 2024
UBS GROUP AG----17-100.00%-Mar 31, 2024
WHITEFORT CAPITAL MANAGEMENT, LP----409,517-100.00%-Mar 31, 2024

Trinity Biotech's largest institutional shareholder is US BANCORP \DE\, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
US BANCORP \DE\----972-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/----1,204-100.00%-Mar 31, 2024
BECKER CAPITAL MANAGEMENT INC----90,000-100.00%-Mar 31, 2024
CITIGROUP INC----4-100.00%-Mar 31, 2024
MORGAN STANLEY----14,552-100.00%-Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----684,882-100.00%-Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC----1,353,898-100.00%-Mar 31, 2024
ATWOOD & PALMER INC----100-100.00%-Mar 31, 2024
RHUMBLINE ADVISERS----1,860-100.00%-Mar 31, 2024
STONEHILL CAPITAL MANAGEMENT LLC----1,512,975-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----15,466-100.00%-Mar 31, 2024
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC----1,625,900-100.00%-Mar 31, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----111,400-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----1,000-100.00%-Mar 31, 2024
TWO SIGMA SECURITIES, LLC----19,037-100.00%-Mar 31, 2024
STATE OF NEW JERSEY COMMON PENSION FUND D----27,062-100.00%-Mar 31, 2024
ARISTIDES CAPITAL LLC----28,057-100.00%-Mar 31, 2024
DYNAMIC ADVISOR SOLUTIONS LLC----10,000-100.00%-Mar 31, 2024
UBS GROUP AG----17-100.00%-Mar 31, 2024
WHITEFORT CAPITAL MANAGEMENT, LP----409,517-100.00%-Mar 31, 2024

The largest Trinity Biotech shareholder by % of total assets is US BANCORP \DE\. The company owns 0.00 shares of Trinity Biotech (TRIB), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CITIGROUP INC----4-100.00%-Mar 31, 2024
UBS GROUP AG----17-100.00%-Mar 31, 2024
ATWOOD & PALMER INC----100-100.00%-Mar 31, 2024
US BANCORP \DE\----972-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----1,000-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/----1,204-100.00%-Mar 31, 2024
CGC FINANCIAL SERVICES, LLC----1,500-100.00%-Mar 31, 2024
RHUMBLINE ADVISERS----1,860-100.00%-Mar 31, 2024
WILLIAMS & NOVAK, LLC----10,000-100.00%-Mar 31, 2024
DYNAMIC ADVISOR SOLUTIONS LLC----10,000-100.00%-Mar 31, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC----14,150-100.00%-Mar 31, 2024
MORGAN STANLEY----14,552-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----15,466-100.00%-Mar 31, 2024
TWO SIGMA SECURITIES, LLC----19,037-100.00%-Mar 31, 2024
CI PRIVATE WEALTH, LLC----22,035-100.00%-Mar 31, 2024
STATE OF NEW JERSEY COMMON PENSION FUND D----27,062-100.00%-Mar 31, 2024
ARISTIDES CAPITAL LLC----28,057-100.00%-Mar 31, 2024
BECKER CAPITAL MANAGEMENT INC----90,000-100.00%-Mar 31, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----111,400-100.00%-Mar 31, 2024
WHITEFORT CAPITAL MANAGEMENT, LP----409,517-100.00%-Mar 31, 2024

As of Mar 31 2024, Trinity Biotech's largest institutional buyer is CITIGROUP INC. The company purchased -4.00 stocks of TRIB, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC----1,625,900-100.00%-Mar 31, 2024
STONEHILL CAPITAL MANAGEMENT LLC----1,512,975-100.00%-Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC----1,353,898-100.00%-Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----684,882-100.00%-Mar 31, 2024
WHITEFORT CAPITAL MANAGEMENT, LP----409,517-100.00%-Mar 31, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----111,400-100.00%-Mar 31, 2024
BECKER CAPITAL MANAGEMENT INC----90,000-100.00%-Mar 31, 2024
ARISTIDES CAPITAL LLC----28,057-100.00%-Mar 31, 2024
STATE OF NEW JERSEY COMMON PENSION FUND D----27,062-100.00%-Mar 31, 2024
CI PRIVATE WEALTH, LLC----22,035-100.00%-Mar 31, 2024
TWO SIGMA SECURITIES, LLC----19,037-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----15,466-100.00%-Mar 31, 2024
MORGAN STANLEY----14,552-100.00%-Mar 31, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC----14,150-100.00%-Mar 31, 2024
DYNAMIC ADVISOR SOLUTIONS LLC----10,000-100.00%-Mar 31, 2024
WILLIAMS & NOVAK, LLC----10,000-100.00%-Mar 31, 2024
RHUMBLINE ADVISERS----1,860-100.00%-Mar 31, 2024
CGC FINANCIAL SERVICES, LLC----1,500-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/----1,204-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----1,000-100.00%-Mar 31, 2024

As of Mar 31 2024, Trinity Biotech's biggest institutional seller is HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC. The company sold -1.63M shares of TRIB, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC----1,625,900-100.00%-Mar 31, 2024
STONEHILL CAPITAL MANAGEMENT LLC----1,512,975-100.00%-Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC----1,353,898-100.00%-Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----684,882-100.00%-Mar 31, 2024
WHITEFORT CAPITAL MANAGEMENT, LP----409,517-100.00%-Mar 31, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----111,400-100.00%-Mar 31, 2024
BECKER CAPITAL MANAGEMENT INC----90,000-100.00%-Mar 31, 2024
ARISTIDES CAPITAL LLC----28,057-100.00%-Mar 31, 2024
STATE OF NEW JERSEY COMMON PENSION FUND D----27,062-100.00%-Mar 31, 2024
CI PRIVATE WEALTH, LLC----22,035-100.00%-Mar 31, 2024
TWO SIGMA SECURITIES, LLC----19,037-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----15,466-100.00%-Mar 31, 2024
MORGAN STANLEY----14,552-100.00%-Mar 31, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC----14,150-100.00%-Mar 31, 2024
DYNAMIC ADVISOR SOLUTIONS LLC----10,000-100.00%-Mar 31, 2024
WILLIAMS & NOVAK, LLC----10,000-100.00%-Mar 31, 2024
RHUMBLINE ADVISERS----1,860-100.00%-Mar 31, 2024
CGC FINANCIAL SERVICES, LLC----1,500-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/----1,204-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----1,000-100.00%-Mar 31, 2024
US BANCORP \DE\----972-100.00%-Mar 31, 2024
ATWOOD & PALMER INC----100-100.00%-Mar 31, 2024
UBS GROUP AG----17-100.00%-Mar 31, 2024
CITIGROUP INC----4-100.00%-Mar 31, 2024

Trinity Biotech's largest sold out institutional shareholder by shares sold is HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, sold -1.63M shares, valued at -, as of undefined.

Trinity Biotech Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
HEARTLAND GROUP INC0.87%492,397--Mar 31, 2024
NORTHERN LIGHTS FUND TRUST II0.02%250,963--Mar 31, 2024
TRUST FOR PROFESSIONAL MANAGERS0.00%78,537--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%5,165--Feb 29, 2024

Trinity Biotech's largest mutual fund holder by % of total assets is "HEARTLAND GROUP INC", owning 492.40K shares, compromising 0.87% of its total assets.

Trinity Biotech Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 232630.00%
30 Sep, 2320-9.09%
30 Jun, 2322-
31 Mar, 232210.00%
31 Dec, 2220-4.76%
30 Sep, 222110.53%
30 Jun, 2219-13.64%
31 Mar, 2222-4.35%
31 Dec, 2123-4.17%
30 Sep, 2124-20.00%
30 Jun, 2130-11.76%
31 Mar, 213436.00%
31 Dec, 20258.70%
30 Sep, 2023-14.81%
30 Jun, 202735.00%
31 Mar, 2020-13.04%
31 Dec, 1923-4.17%
30 Sep, 1924-27.27%
30 Jun, 1933-5.71%
31 Mar, 1935-7.89%
31 Dec, 1838-11.63%
30 Sep, 1843-
30 Jun, 1843-2.27%
31 Mar, 1844-4.35%
31 Dec, 1746-11.54%
30 Sep, 1752-5.45%
30 Jun, 1755-17.91%
31 Mar, 1767-6.94%
31 Dec, 1672-10.00%
30 Sep, 1680-2.44%
30 Jun, 16822.50%
31 Mar, 1680-2.44%
31 Dec, 1582-11.83%
30 Sep, 1593-
30 Jun, 15934.49%
31 Mar, 1589-4.30%
31 Dec, 1493-3.13%
30 Sep, 14962.13%
30 Jun, 149416.05%
31 Mar, 14818.00%
31 Dec, 13755.63%
30 Sep, 137116.39%
30 Jun, 1361134.62%
31 Mar, 1326-18.75%
31 Dec, 123223.08%
30 Sep, 1226-3.70%
30 Jun, 122735.00%
31 Mar, 122011.11%
31 Dec, 1118-
30 Sep, 1118-18.18%
30 Jun, 112257.14%
31 Mar, 111455.56%
31 Dec, 109-18.18%
30 Sep, 101110.00%
30 Jun, 1010-
31 Mar, 1010100.00%
31 Dec, 095-28.57%
30 Sep, 097-12.50%
30 Jun, 09814.29%
31 Mar, 097-12.50%
31 Dec, 088-20.00%
30 Sep, 0810-9.09%
30 Jun, 0811-
31 Mar, 0811-8.33%
31 Dec, 071233.33%
30 Sep, 079-30.77%
30 Jun, 07138.33%
31 Mar, 0712-14.29%
31 Dec, 061440.00%
30 Sep, 0610-
30 Jun, 0610100.00%
31 Mar, 06525.00%
31 Dec, 054-33.33%
30 Sep, 05650.00%
30 Jun, 054-

As of 31 Dec 23, 26 institutions are holding Trinity Biotech's shares, representing an increase of 30.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 236,017,301-1.94%
30 Sep, 236,136,275-1.08%
30 Jun, 236,203,359-1.88%
31 Mar, 236,322,223-3.85%
31 Dec, 226,575,585-6.26%
30 Sep, 227,015,017-3.83%
30 Jun, 227,294,511-19.12%
31 Mar, 229,018,90767.35%
31 Dec, 215,389,374-2.29%
30 Sep, 215,515,9385.70%
30 Jun, 215,218,575-2.83%
31 Mar, 215,370,757-9.01%
31 Dec, 205,902,766-5.58%
30 Sep, 206,251,351-14.14%
30 Jun, 207,280,823-17.06%
31 Mar, 208,778,586-15.77%
31 Dec, 1910,422,714-1.95%
30 Sep, 1910,629,465-10.08%
30 Jun, 1911,820,793-9.67%
31 Mar, 1913,086,618-0.93%
31 Dec, 1813,209,757-7.64%
30 Sep, 1814,301,903-1.31%
30 Jun, 1814,492,407-4.86%
31 Mar, 1815,232,9182.06%
31 Dec, 1714,924,9452.76%
30 Sep, 1714,524,438-2.72%
30 Jun, 1714,929,920-5.04%
31 Mar, 1715,722,155-0.20%
31 Dec, 1615,753,811-5.35%
30 Sep, 1616,645,080-1.38%
30 Jun, 1616,878,482-2.52%
31 Mar, 1617,314,0520.20%
31 Dec, 1517,279,607-6.33%
30 Sep, 1518,447,4345.20%
30 Jun, 1517,535,93811.43%
31 Mar, 1515,736,9063.58%
31 Dec, 1415,193,4427.98%
30 Sep, 1414,070,4612.04%
30 Jun, 1413,789,1353.47%
31 Mar, 1413,327,2186.97%
31 Dec, 1312,458,4618.12%
30 Sep, 1311,522,9737.17%
30 Jun, 1310,752,44560.90%
31 Mar, 136,682,816-14.54%
31 Dec, 127,819,92910.41%
30 Sep, 127,082,744-1.97%
30 Jun, 127,224,84698.58%
31 Mar, 123,638,207-24.09%
31 Dec, 114,792,690-17.85%
30 Sep, 115,834,3595.97%
30 Jun, 115,505,75588.34%
31 Mar, 112,923,29942.57%
31 Dec, 102,050,459-60.02%
30 Sep, 105,128,14997.54%
30 Jun, 102,595,964-44.90%
31 Mar, 104,710,99419.95%
31 Dec, 093,927,46910.05%
30 Sep, 093,568,93764.60%
30 Jun, 092,168,265-7.08%
31 Mar, 092,333,354-25.11%
31 Dec, 083,115,780-25.19%
30 Sep, 084,164,940-3.97%
30 Jun, 084,337,28614.63%
31 Mar, 083,783,71519.80%
31 Dec, 073,158,40563.18%
30 Sep, 071,935,579-4.91%
30 Jun, 072,035,601194.34%
31 Mar, 07691,590-31.46%
31 Dec, 061,009,03335.87%
30 Sep, 06742,651-21.45%
30 Jun, 06945,482-9.01%
31 Mar, 061,039,06329.00%
31 Dec, 05805,48930.62%
30 Sep, 05616,6823.55%
30 Jun, 05595,520-

Trinity Biotech (TRIB) has 6.02M shares outstanding as of 31 Dec 23, down -1.94% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 2315.70%6.11%
30 Sep, 2316.03%6.05%
30 Jun, 2316.28%5.91%
31 Mar, 2316.59%5.57%
31 Dec, 2217.26%5.09%
30 Sep, 2218.41%2.09%
30 Jun, 2229.68%2.20%
31 Mar, 2236.70%5.52%
31 Dec, 2125.78%3.70%
30 Sep, 2126.39%4.23%
30 Jun, 2124.97%3.78%
31 Mar, 2125.70%3.22%
31 Dec, 2028.24%3.16%
30 Sep, 2029.91%2.46%
30 Jun, 2034.83%1.97%
31 Mar, 2042.00%1.69%
31 Dec, 1949.87%1.93%
30 Sep, 1950.85%1.59%
30 Jun, 1956.55%1.44%
31 Mar, 1962.61%1.57%
31 Dec, 1863.19%1.35%
30 Sep, 1868.42%1.42%
30 Jun, 1869.34%1.31%
31 Mar, 1872.86%1.46%
31 Dec, 1770.63%1.53%
30 Sep, 1767.94%1.45%
30 Jun, 1768.34%1.35%
31 Mar, 1771.13%1.48%
31 Dec, 1669.21%1.30%
30 Sep, 1673.01%1.36%
30 Jun, 1673.33%1.33%
31 Mar, 1674.35%1.35%
31 Dec, 1574.29%1.18%
30 Sep, 1579.51%1.39%
30 Jun, 1575.60%1.61%
31 Mar, 1568.47%1.54%
31 Dec, 1466.79%1.77%
30 Sep, 1461.42%1.67%
30 Jun, 1460.74%1.73%
31 Mar, 1459.32%1.89%
31 Dec, 1355.96%2.04%
30 Sep, 1352.35%2.13%
30 Jun, 1349.63%5.20%
31 Mar, 1330.89%2.32%
31 Dec, 1236.51%3.37%
30 Sep, 1232.92%2.87%
30 Jun, 1233.85%11.51%
31 Mar, 1217.15%3.36%
31 Dec, 1122.59%3.01%
30 Sep, 1127.39%4.12%
30 Jun, 1125.79%13.80%
31 Mar, 1113.67%14.59%
31 Dec, 109.68%1.65%
30 Sep, 1024.21%16.01%
30 Jun, 1012.30%2.46%
31 Mar, 1022.34%6.35%
31 Dec, 0918.76%6.46%
30 Sep, 0917.04%15.77%
30 Jun, 0910.40%8.30%
31 Mar, 0911.19%5.01%
31 Dec, 0814.94%3.75%
30 Sep, 0819.97%4.52%
30 Jun, 0821.02%5.32%
31 Mar, 0819.87%7.05%
31 Dec, 0716.79%16.19%
30 Sep, 0710.18%8.87%
30 Jun, 0710.71%80.63%
31 Mar, 073.64%12.89%
31 Dec, 065.32%32.99%
30 Sep, 064.01%14.63%
30 Jun, 065.24%11.46%
31 Mar, 066.76%24.61%
31 Dec, 055.24%30.40%
30 Sep, 054.15%24.38%
30 Jun, 054.13%-

As of 31 Dec 23, Trinity Biotech is held by 15.70% institutional shareholders, representing a 6.11% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 236200.00%
30 Sep, 232-50.00%
30 Jun, 234-
31 Mar, 234-33.33%
31 Dec, 226100.00%
30 Sep, 223-25.00%
30 Jun, 224-60.00%
31 Mar, 221025.00%
31 Dec, 218-11.11%
30 Sep, 219-10.00%
30 Jun, 2110-28.57%
31 Mar, 21147.69%
31 Dec, 201330.00%
30 Sep, 2010-28.57%
30 Jun, 2014180.00%
31 Mar, 205-44.44%
31 Dec, 19950.00%
30 Sep, 196-40.00%
30 Jun, 1910-
31 Mar, 191025.00%
31 Dec, 188-33.33%
30 Sep, 1812-7.69%
30 Jun, 181318.18%
31 Mar, 1811-21.43%
31 Dec, 1714-17.65%
30 Sep, 171713.33%
30 Jun, 1715-48.28%
31 Mar, 1729-17.14%
31 Dec, 163529.63%
30 Sep, 162712.50%
30 Jun, 1624-45.45%
31 Mar, 1644-8.33%
31 Dec, 1548-2.04%
30 Sep, 154919.51%
30 Jun, 15412.50%
31 Mar, 1540-20.00%
31 Dec, 1450-1.96%
30 Sep, 1451-7.27%
30 Jun, 145537.50%
31 Mar, 1440-6.98%
31 Dec, 13434.88%
30 Sep, 1341-10.87%
30 Jun, 1346170.59%
31 Mar, 1317-5.56%
31 Dec, 121812.50%
30 Sep, 1216-
30 Jun, 121660.00%
31 Mar, 1210-9.09%
31 Dec, 111122.22%
30 Sep, 119-30.77%
30 Jun, 111385.71%
31 Mar, 117250.00%
31 Dec, 102-60.00%
30 Sep, 105-
30 Jun, 105-16.67%
31 Mar, 10650.00%
31 Dec, 094-20.00%
30 Sep, 095-16.67%
30 Jun, 096200.00%
31 Mar, 092-
31 Dec, 082-66.67%
30 Sep, 086-25.00%
30 Jun, 08814.29%
31 Mar, 087-12.50%
31 Dec, 078700.00%
30 Sep, 071-87.50%
30 Jun, 07814.29%
31 Mar, 077-22.22%
31 Dec, 06928.57%
30 Sep, 067-30.00%
30 Jun, 0610150.00%
31 Mar, 06433.33%
31 Dec, 053-25.00%
30 Sep, 054-
30 Jun, 054-

6 institutional shareholders have increased their position in TRIB stock as of 31 Dec 23 compared to 2 in the previous quarter (a 200.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 23650.00%
30 Sep, 234-
30 Jun, 234-42.86%
31 Mar, 237-12.50%
31 Dec, 22814.29%
30 Sep, 227-12.50%
30 Jun, 22833.33%
31 Mar, 226-
31 Dec, 216-14.29%
30 Sep, 217-12.50%
30 Jun, 218-33.33%
31 Mar, 211250.00%
31 Dec, 208100.00%
30 Sep, 204-33.33%
30 Jun, 206-
31 Mar, 206-
31 Dec, 196-33.33%
30 Sep, 199-25.00%
30 Jun, 19129.09%
31 Mar, 1911-26.67%
31 Dec, 1815-
30 Sep, 181515.38%
30 Jun, 1813-
31 Mar, 1813-13.33%
31 Dec, 1715-
30 Sep, 1715-25.00%
30 Jun, 17205.26%
31 Mar, 1719-9.52%
31 Dec, 1621-32.26%
30 Sep, 16313.33%
30 Jun, 163036.36%
31 Mar, 1622-
31 Dec, 1522-18.52%
30 Sep, 1527-10.00%
30 Jun, 15303.45%
31 Mar, 1529-
31 Dec, 1429-3.33%
30 Sep, 143042.86%
30 Jun, 1421-27.59%
31 Mar, 142938.10%
31 Dec, 1321-
30 Sep, 1321110.00%
30 Jun, 131042.86%
31 Mar, 137-30.00%
31 Dec, 1210150.00%
30 Sep, 124-33.33%
30 Jun, 12620.00%
31 Mar, 12566.67%
31 Dec, 113-40.00%
30 Sep, 11566.67%
30 Jun, 113-25.00%
31 Mar, 114-
31 Dec, 104100.00%
30 Sep, 102-33.33%
30 Jun, 103-25.00%
31 Mar, 104300.00%
31 Dec, 091-50.00%
30 Sep, 092-
30 Jun, 092-33.33%
31 Mar, 093-25.00%
31 Dec, 084100.00%
30 Sep, 082-
30 Jun, 082100.00%
31 Mar, 081-50.00%
31 Dec, 072-50.00%
30 Sep, 074100.00%
30 Jun, 072-60.00%
31 Mar, 075400.00%
31 Dec, 061-
30 Sep, 061-
30 Jun, 06--
31 Mar, 06--
31 Dec, 05--100.00%
30 Sep, 051-
30 Jun, 05--

6 institutional shareholders have reduced their position in TRIB stock as of 31 Dec 23 compared to 4 in the previous quarter (a 50.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 232630.00%6,017,301-1.94%15.70%6.11%6200.00%650.00%
30 Sep, 2320-9.09%6,136,275-1.08%16.03%6.05%2-50.00%4-
30 Jun, 2322-6,203,359-1.88%16.28%5.91%4-4-42.86%
31 Mar, 232210.00%6,322,223-3.85%16.59%5.57%4-33.33%7-12.50%
31 Dec, 2220-4.76%6,575,585-6.26%17.26%5.09%6100.00%814.29%
30 Sep, 222110.53%7,015,017-3.83%18.41%2.09%3-25.00%7-12.50%
30 Jun, 2219-13.64%7,294,511-19.12%29.68%2.20%4-60.00%833.33%
31 Mar, 2222-4.35%9,018,90767.35%36.70%5.52%1025.00%6-
31 Dec, 2123-4.17%5,389,374-2.29%25.78%3.70%8-11.11%6-14.29%
30 Sep, 2124-20.00%5,515,9385.70%26.39%4.23%9-10.00%7-12.50%
30 Jun, 2130-11.76%5,218,575-2.83%24.97%3.78%10-28.57%8-33.33%
31 Mar, 213436.00%5,370,757-9.01%25.70%3.22%147.69%1250.00%
31 Dec, 20258.70%5,902,766-5.58%28.24%3.16%1330.00%8100.00%
30 Sep, 2023-14.81%6,251,351-14.14%29.91%2.46%10-28.57%4-33.33%
30 Jun, 202735.00%7,280,823-17.06%34.83%1.97%14180.00%6-
31 Mar, 2020-13.04%8,778,586-15.77%42.00%1.69%5-44.44%6-
31 Dec, 1923-4.17%10,422,714-1.95%49.87%1.93%950.00%6-33.33%
30 Sep, 1924-27.27%10,629,465-10.08%50.85%1.59%6-40.00%9-25.00%
30 Jun, 1933-5.71%11,820,793-9.67%56.55%1.44%10-129.09%
31 Mar, 1935-7.89%13,086,618-0.93%62.61%1.57%1025.00%11-26.67%
31 Dec, 1838-11.63%13,209,757-7.64%63.19%1.35%8-33.33%15-
30 Sep, 1843-14,301,903-1.31%68.42%1.42%12-7.69%1515.38%
30 Jun, 1843-2.27%14,492,407-4.86%69.34%1.31%1318.18%13-
31 Mar, 1844-4.35%15,232,9182.06%72.86%1.46%11-21.43%13-13.33%
31 Dec, 1746-11.54%14,924,9452.76%70.63%1.53%14-17.65%15-
30 Sep, 1752-5.45%14,524,438-2.72%67.94%1.45%1713.33%15-25.00%
30 Jun, 1755-17.91%14,929,920-5.04%68.34%1.35%15-48.28%205.26%
31 Mar, 1767-6.94%15,722,155-0.20%71.13%1.48%29-17.14%19-9.52%
31 Dec, 1672-10.00%15,753,811-5.35%69.21%1.30%3529.63%21-32.26%
30 Sep, 1680-2.44%16,645,080-1.38%73.01%1.36%2712.50%313.33%
30 Jun, 16822.50%16,878,482-2.52%73.33%1.33%24-45.45%3036.36%
31 Mar, 1680-2.44%17,314,0520.20%74.35%1.35%44-8.33%22-
31 Dec, 1582-11.83%17,279,607-6.33%74.29%1.18%48-2.04%22-18.52%
30 Sep, 1593-18,447,4345.20%79.51%1.39%4919.51%27-10.00%
30 Jun, 15934.49%17,535,93811.43%75.60%1.61%412.50%303.45%
31 Mar, 1589-4.30%15,736,9063.58%68.47%1.54%40-20.00%29-
31 Dec, 1493-3.13%15,193,4427.98%66.79%1.77%50-1.96%29-3.33%
30 Sep, 14962.13%14,070,4612.04%61.42%1.67%51-7.27%3042.86%
30 Jun, 149416.05%13,789,1353.47%60.74%1.73%5537.50%21-27.59%
31 Mar, 14818.00%13,327,2186.97%59.32%1.89%40-6.98%2938.10%
31 Dec, 13755.63%12,458,4618.12%55.96%2.04%434.88%21-
30 Sep, 137116.39%11,522,9737.17%52.35%2.13%41-10.87%21110.00%
30 Jun, 1361134.62%10,752,44560.90%49.63%5.20%46170.59%1042.86%
31 Mar, 1326-18.75%6,682,816-14.54%30.89%2.32%17-5.56%7-30.00%
31 Dec, 123223.08%7,819,92910.41%36.51%3.37%1812.50%10150.00%
30 Sep, 1226-3.70%7,082,744-1.97%32.92%2.87%16-4-33.33%
30 Jun, 122735.00%7,224,84698.58%33.85%11.51%1660.00%620.00%
31 Mar, 122011.11%3,638,207-24.09%17.15%3.36%10-9.09%566.67%
31 Dec, 1118-4,792,690-17.85%22.59%3.01%1122.22%3-40.00%
30 Sep, 1118-18.18%5,834,3595.97%27.39%4.12%9-30.77%566.67%
30 Jun, 112257.14%5,505,75588.34%25.79%13.80%1385.71%3-25.00%
31 Mar, 111455.56%2,923,29942.57%13.67%14.59%7250.00%4-
31 Dec, 109-18.18%2,050,459-60.02%9.68%1.65%2-60.00%4100.00%
30 Sep, 101110.00%5,128,14997.54%24.21%16.01%5-2-33.33%
30 Jun, 1010-2,595,964-44.90%12.30%2.46%5-16.67%3-25.00%
31 Mar, 1010100.00%4,710,99419.95%22.34%6.35%650.00%4300.00%
31 Dec, 095-28.57%3,927,46910.05%18.76%6.46%4-20.00%1-50.00%
30 Sep, 097-12.50%3,568,93764.60%17.04%15.77%5-16.67%2-
30 Jun, 09814.29%2,168,265-7.08%10.40%8.30%6200.00%2-33.33%
31 Mar, 097-12.50%2,333,354-25.11%11.19%5.01%2-3-25.00%
31 Dec, 088-20.00%3,115,780-25.19%14.94%3.75%2-66.67%4100.00%
30 Sep, 0810-9.09%4,164,940-3.97%19.97%4.52%6-25.00%2-
30 Jun, 0811-4,337,28614.63%21.02%5.32%814.29%2100.00%
31 Mar, 0811-8.33%3,783,71519.80%19.87%7.05%7-12.50%1-50.00%
31 Dec, 071233.33%3,158,40563.18%16.79%16.19%8700.00%2-50.00%
30 Sep, 079-30.77%1,935,579-4.91%10.18%8.87%1-87.50%4100.00%
30 Jun, 07138.33%2,035,601194.34%10.71%80.63%814.29%2-60.00%
31 Mar, 0712-14.29%691,590-31.46%3.64%12.89%7-22.22%5400.00%
31 Dec, 061440.00%1,009,03335.87%5.32%32.99%928.57%1-
30 Sep, 0610-742,651-21.45%4.01%14.63%7-30.00%1-
30 Jun, 0610100.00%945,482-9.01%5.24%11.46%10150.00%--
31 Mar, 06525.00%1,039,06329.00%6.76%24.61%433.33%--
31 Dec, 054-33.33%805,48930.62%5.24%30.40%3-25.00%--100.00%
30 Sep, 05650.00%616,6823.55%4.15%24.38%4-1-
30 Jun, 054-595,520-4.13%-4---

Trinity Biotech Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION10 percent owner-S-SaleSell65,200$52.04$3.39M38,238,876
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION10 percent owner-S-SaleSell92,000$52.40$4.82M38,238,876
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION10 percent owner-S-SaleSell17,800$51.94$924.52K38,238,876

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION10 percent owner-S-SaleSell65,200$52.04$3.39M38,238,876
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION10 percent owner-S-SaleSell92,000$52.40$4.82M38,238,876
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION10 percent owner-S-SaleSell17,800$51.94$924.52K38,238,876

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION10 percent owner-S-SaleSell65,200$52.04$3.39M38,238,876
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION10 percent owner-S-SaleSell92,000$52.40$4.82M38,238,876
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION10 percent owner-S-SaleSell17,800$51.94$924.52K38,238,876

The last insider sell of Trinity Biotech's stock was made by ROBERT R MCCORMICK TRIBUNE FOUNDATION on Feb 19 2004, selling 65,200 shares at $52.04 per share (valued at $3.39M).

Trinity Biotech Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio

Trinity Biotech Peer Ownership


TickerCompany
GTHGenetron Holdings Limited
LABStandard BioTools Inc.
XGNExagen Inc.
SERASera Prognostics, Inc.
PREPrenetics Global Limited
CSTLCastle Biosciences, Inc.
ACRSAclaris Therapeutics, Inc.
NOTVInotiv, Inc.
NDRAENDRA Life Sciences Inc.
OLKOlink Holding AB (publ)
BDSXBiodesix, Inc.
FONRFONAR Corporation
STIMNeuronetics, Inc.
SHCSotera Health Company
MDXHMDxHealth SA

TRIB Ownership FAQ


Trinity Biotech is owned by institutional shareholders (15.70%), insiders (19.68%), and public (64.62%). The largest institutional shareholder of Trinity Biotech is US BANCORP \DE\ (0% of total shares) and the top mutual fund owner is HEARTLAND GROUP INC (0.87% of total shares).

Trinity Biotech's major institutional shareholders are US BANCORP \DE\, BANK OF AMERICA CORP /DE/, BECKER CAPITAL MANAGEMENT INC, CITIGROUP INC, and MORGAN STANLEY. The top five shareholders own together 0% of the company's share outstanding.

As of Dec 2023, there are 26 institutional shareholders of Trinity Biotech.

US BANCORP \DE\ owns 0 shares of Trinity Biotech, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).

As of Mar 2024, BANK OF AMERICA CORP /DE/ holds 0 shares of Trinity Biotech (TRIB), compromising 0% of the company, valued at $0.

BECKER CAPITAL MANAGEMENT INC is the third largest holder of Trinity Biotech. The company owns 0 of the company's shares outstanding (worth $0).